Edition:
India

Strides Shasun Ltd (STSA.NS)

STSA.NS on National Stock Exchange of India

411.40INR
3:55pm IST
Change (% chg)

Rs-0.20 (-0.05%)
Prev Close
Rs411.60
Open
Rs413.00
Day's High
Rs422.00
Day's Low
Rs407.55
Volume
4,590,018
Avg. Vol
2,599,843
52-wk High
Rs1,102.20
52-wk Low
Rs333.30

Chart for

About

Strides Shasun Limited, formerly Strides Arcolab Limited, is a vertically integrated global pharmaceutical company. The Company is engaged in the development and manufacturing of active pharmaceutical ingredients (APIs) and formulations, as well as biotech. Its business segments include Pharmaceutical and Biotech businesses. Its... (more)

Overall

Beta: 0.59
Market Cap(Mil.): Rs74,972.77
Shares Outstanding(Mil.): 89.49
Dividend: 4.50
Yield (%): 0.54

Financials

  STSA.NS Industry Sector
P/E (TTM): 21.94 30.95 32.74
EPS (TTM): 38.19 -- --
ROI: -- 14.84 14.38
ROE: -- 16.34 16.08

Sensex hits over four-month closing high

Indian shares rose on Tuesday, in line with broader Asian peers, as sentiment turned upbeat after U.S. President Donald Trump and North Korean leader Kim Jong Un pledged to work towards complete denuclearisation of the Korean peninsula.

12 Jun 2018

BUZZ-India's Strides Shasun rises on US FDA nod for flu treatment

** Shares of Strides Shasun Ltd climb as much as 5.5 pct to 369 rupees

12 Jun 2018

RPT-ICRA ratings for Indian debt instruments-May 29

(Repeating to add additional ratings as of May 28, 2018) May 29 Below are the ratings awarded by Investment Information Credit Rating Agency Ltd. (ICRA) for local debt instruments as of May 28, 2018. COMPANY INSTRUMENT RATING AMOUNT MOVEMENT (RS.MLN) ------ ---------- ------ ----- --------- SHORT TERM RAT

30 May 2018

BUZZ-India's Strides Shasun extends losses on disappointing Q4

** Shares in pharmaceutical company Strides Shasun Ltd slip for a second session; fall as much as 8.7 pct to 353.40 rupees, lowest since April 2014

21 May 2018

BUZZ-India's Strides Shasun plunges, loses most in over 10 years

** Shares of Strides Shasun Ltd dives nearly 25 pct to 378.20 rupees, their lowest since early April 2014

18 May 2018

BRIEF-India's Strides Shasun March-Qtr Consol Profit Rises Five-Fold

* MARCH QUARTER CONSOL NET PROFIT 5.68 BILLION RUPEES VERSUS PROFIT OF 1.12 BILLION RUPEES LAST YEAR

18 May 2018

RPT-ICRA ratings for Indian debt instruments-May 17

(Repeating to add more ratings) May 17 Below are the ratings awarded by Investment Information Credit Rating Agency Ltd. (ICRA) for local debt instruments as of May 16, 2018. COMPANY INSTRUMENT RATING AMOUNT MOVEMENT (RS.MLN) ------ ---------- ------ ----- --------- SHORT TERM RATINGS: ------------------

18 May 2018

BUZZ-India's Strides Shasun rises after merger deal with Apotex

** Shares in Strides Shasun Ltd rise as much as 2.6 pct to 566.60 rupees

09 May 2018

BRIEF-India's Strides Shasun Gets U.S. FDA Nod For Cinacalcet Hydrochloride Tablets

* STRIDES SHASUN RECEIVES USFDA APPROVAL FOR CINACALCET HYDROCHLORIDE TABLETS

02 May 2018

BRIEF-Strides Shasun To Divest Holding In Remaining API Asset At Ambernath

* SAYS TO DIVEST ITS HOLDING IN REMAINING API ASSET AT AMBERNATH TO SOLARA ACTIVE PHARMA SCIENCES LIMITED

24 Apr 2018

Earnings vs. Estimates